相关实验视频

Updated: Jul 30, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

针对HSC基因治疗的CD90向的晶状病毒载体

Kurt Berckmueller¹, Justin Thomas¹, Eman A Taha²

¹Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Molecular therapy : the journal of the American Society of Gene Therapy

|August 8, 2023

概括

研究人员开发了针对CD90的新型病毒载体,以特别修改罕见的造血干细胞 (HSC). 这一进步增强了ex vivo基因疗法的可行性,并为未来的in vivo应用提供了潜力.

科学领域:

分子生物学分子生物学
基因治疗基因治疗
血液学血液学血液学

背景情况:

目前的造血干细胞 (HSC) 基因疗法使用CD34+细胞,含有很少真正的HSC,需要复杂的基础设施.
CD34+CD90+子集对于移植至关重要,但其隔离是困难和昂贵的.
缺乏特定于HSC的传递剂阻碍了罕见HSC的直接修饰.

研究的目的:

开发新的向病毒载体,用于CD90表达HSC的特定转导.
通过直接修改罕见的HSCs来克服当前HSC基因疗法的局限性.

主要方法:

工程化麻疹和VSV-G伪型的lentiviral载体与抗CD90单链可变片段 (scFvs).
开发了一种定制的水力动力学定位方法,用于矢量表征.
评估载体性能,包括囊载荷,抗原识别和细胞融合能力.

主要成果:

工程载体在功能标位上表现出最小的损伤,并保持了细胞融合能力.
载体表现出在细胞上对CD90的高度特异性识别.
目标载体选择性地转化了具有二次殖民地形成潜力的人类HSCs.

结论:

成功开发了针对HSC的新型病毒载体.
这些载体使罕见的HSCs能够进行特定的转导,从而提高了ex vivo基因治疗的可行性.
这项技术有可能在未来的 in vivo 基因治疗应用中发挥作用.

关键词:

CD9090 CD9090 CD9090 CD9090 CD9090 CD9090 CD9090 CD9090 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 CD90 针对HSC的目标定位在HSCs中,HSCs是最重要的.在VSVG中,VSVG是VSVG.基因治疗的基因疗法造血干细胞造血干细胞麻疹是一种麻疹.scFvv 在线阅读单链变量碎片单链变量碎片表面工程病毒载体的表面工程病毒载体

更多相关视频

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...